Automatic Website Traffic RSS

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-related caution for medications—for all chimeric ... read more

From 'conspiracy theory' to 'cover-up'? Agencies hid 2018 pitch to fund chimeric coronavirus

"At a minimum, everyone associated with the DEFUSE proposal should be permanently debarred from receiving future federal funding," Rutgers University biosafety advocate says after Senator Paul's ... read more

Chimeric Antigen Receptor Macrophage (CAR-M) Immunotherapy Drug Pipeline Research 2024

The "Chimeric Antigen Receptor Macrophage (CAR-M) Immunotherapy - Pipeline Insight, 2024" drug pipelines has been added tAndMarkets.com's offering.The report outlays comprehensive insights of present ... read more

FDA Calls for Boxed Warnings for CAR T-Cell Immunotherapies

Following an investigation that began in November 2023, the FDA now requires boxed warnings regarding T-cell malignancies on all BCMA- and CD19-directed T-cell products. read more

What We’re Reading: Health Care Antitrust Portal; CAR T Label Updates; Weight-Loss Shots and Fertility

Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric ... read more

FDA Approves a Phase 1 Trial for Investigational Therapy, CB-010, for Lupus Nephritis Treatment

The U.S. Food & Drug Administration has granted approval for a Phase 1 study to evaluate the safety and efficacy of investigational therapy, CB-010, for treatment of lupus nephritis (LN). read more

Closing Thoughts: Richardson on Myeloma Maintenance Therapy

Paul Richardson, MD, concludes his conversation by briefly discussing additional trials influencing the multiple myeloma treatment landscape, as well as the use of iberdomide. read more

2seventy bio (TSVT) Rises More Than 50% in 3 Months: Here's Why

Shares of 2seventy bio, Inc. TSVT have rallied 51.4% in the past three months against the industry’s decrease of 7.6%. The company is developing and commercializing its chimeric antigen receptor (CAR) ... read more

To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation

However, with risk comes reward. If a fund can smartly predict the trends of tomorrow, significant upside exists. read more

Century Therapeutics gets grant for universal chimeric antigen receptor system with adaptable receptor specificity

Revolutionize disease treatment with Century Therapeutics' patented universal chimeric antigen receptor system. Discover how this adaptable system uses immune effector cells and soluble polypeptides ... read more

Where to Drink Wine During the Venice Biennale, According to an Expert

Antica Terra founder Maggie Harrison shares her favorite spots to imbibe as this year’s art Biennale kicks into high gear. read more

Johnson & Johnson reports net earnings of $5.3bn in Q1 2024

J ohnson & Johnson has reported a notable increase in its financial performance for the first quarter (Q1) of 2024, with net earnings reaching $5.3bn compared to a loss of $491m in the same period of ... read more